Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4]
New Microbes New Infect. 2015 Jul 31:8:174.
doi: 10.1016/j.nmni.2015.07.004.
eCollection 2015 Nov.
2 Laboratory of Virology, Department of Genetics and Laboratory Medicine, Switzerland.
3 Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva, Switzerland.
4 Department of Clinical Pharmaco-Toxicology, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France.
5 Division of Infectious Diseases, Department of Medical Specialties, Geneva University, Geneva, Switzerland.
6 Division of Infectious Diseases, Department of Medical Specialties, Geneva University, Geneva, Switzerland; Infectious Diseases Department, Hospital-Clinic-IDIBAPS, Barcelona, Spain.